Investigating locations of recurrences with MRI after CRS-HIPEC for colorectal peritoneal metastases

• Published in: European journal of radiology 2024-06, Vol.175, p.111478-111478, Article 111478
• Main Authors: Rijsemus, C.J.V., Kok, N.F.M., Aalbers, A.G.J., Grotenhuis, B.A., Berardi, E., Snaebjornsson, P., Lambregts, D.M.J., Beets-Tan, R.G.H., Lahaye, M.J.
• Format: Article
• Language: English
• Subjects: (DW) MRI; Adult; Aged; Colorectal cancer; Colorectal Neoplasms - diagnostic imaging; Colorectal Neoplasms - pathology; Combined Modality Therapy; CRS-HIPEC; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermic Intraperitoneal Chemotherapy; Magnetic Resonance Imaging - methods; Male; Middle Aged; Neoplasm Recurrence, Local - diagnostic imaging; PCI; Peritoneal metastases; Peritoneal Neoplasms - diagnostic imaging; Peritoneal Neoplasms - secondary; Peritoneal Neoplasms - therapy; Recurrence; Retrospective Studies
• ISSN: 0720-048X; 1872-7727
• DOI: 10.1016/j.ejrad.2024.111478

Patients with colorectal peritoneal metastases (PM) treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are at high risk of recurrent disease. Understanding where and why recurrences occur is the first step in finding solutions to reduce recurrence rates. Although diffusion-weighted (DW) MRI is not routinely used in the follow-up of CRC patients, it has a clear advantage over CT in detecting the location and spread of (recurrent) PM. This study aimed to identify common locations of recurrence in CRC patients after CRS-HIPEC with MRI. This was a single-centre retrospective study of patients with recurrent PM after CRS-HIPEC performed between January 2016 and August 2020. Patients were eligible for inclusion if they had both an MRI preoperatively (MRI1) and at the time of recurrent disease (MRI2). Two abdominal radiologists reviewed in consensus and categorized recurrences according to their location on MRI2 and in correlation with previous disease location on prior imaging (MRI1) and the surgical report of the CRS-HIPEC. Thirty patients were included, with a median surgical PCI of 7 (range 3–21) at the time of primary CRS-HIPEC. In total, 68 recurrent metastases were detected on MRI2, of which 14 were extra-peritoneal. Of the remaining 54 PM, 42 (78%) occurred where the peritoneum was damaged due to earlier resections or other surgical procedures (e.g. inserted surgical abdominal drains). Most recurrent metastases were found in the mesentery, lower abdomen/pelvis and abdominal wall (87%). Most recurrent PMs appeared in the mesentery, lower abdomen/pelvis and abdominal wall, especially where the peritoneum was previously damaged.